Suppr超能文献

注射利培酮的大鼠对体重过度增加的抗性。

Resistance to excessive bodyweight gain in risperidone-injected rats.

作者信息

Ota Miyuki, Mori Keiji, Nakashima Akira, Kaneko Yoko S, Takahashi Hisahide, Ota Akira

机构信息

Department of Neuropsychiatry, Tosei General Hospital, Seto, Japan.

出版信息

Clin Exp Pharmacol Physiol. 2005 Apr;32(4):279-87. doi: 10.1111/j.1440-1681.2005.04184.x.

Abstract
  1. The present study was carried out to explain the resistance of rats injected subcutaneously with risperidone, the atypical antipsychotic drug, for 21 consecutive days at 0.1 mg/kg per day (a dose equivalent to the one used for patients) to result in an excessive bodyweight despite the increase in diet-uptake in rats against risperidone-induced decrease in body temperature. 2. Rectal temperature measurements were made in 8-week-old male Sprague-Dawley rats maintained under standard laboratory conditions using a 12 h daylight cycle. A s.c. injection of risperidone (0.05 mg/kg) produced hypothermia in rats, which was observed during the daily injection for 21 consecutive days. 3. Sera, white and brown adipose tissues, skeletal muscle and liver were extracted from 8-week-old male Sprague-Dawley rats injected subcutaneously with risperidone (0.01 or 0.1 mg/kg per day) or a vehicle for 21 consecutive days. Serum levels of lipids, ketones and thyroid hormone were measured. The mRNA expression levels in these tissues and organs of the genes encoding the substances involved in heat production and/or lipid metabolism were investigated by using quantitative real-time polymerase chain reaction amplification. 4. Serum nonesterified fatty acid levels in risperidone 0.1 mg/kg per day s.c. injected rats were significantly lower than those in vehicle-injected ones. Serum beta-hydroxybutyrate levels in risperidone-injected rats tended to decrease compared with those in vehicle-injected ones. The serum level of neither triiodothyronine nor thyroxine was affected by risperidone s.c. injection at the doses examined, although their values were within normal limits. 5. Risperidone injection (0.1 mg/kg per day) for 21 consecutive days upregulated mRNA expressions in white adipose tissue of uncoupling protein 3 which dissipates energy as heat; peroxisome proliferator-activated receptor (PPAR) gamma coactivator 1alpha which activates mitochondrial biogenesis to expand the oxidative machinery; and PPARalpha which is necessary for the fat-depletion of adipocytes for thermogenesis. The mRNA of lipogenic enzymes (acetyl-CoA carboxylase alpha, fatty-acid synthase and glycerol-3-phosphate acyltransferase), hormone sensitive lipase and beta1-adrenoceptor were also enhanced in white adipose tissue by the injection of 0.1 mg/kg per day risperidone. 6. These findings suggest that the materials for heat generation in white adipose tissue would be readily supplied, which in turn would reduce a storage of lipids in white adipose tissue resulting in the lower rate of bodyweight gain of rats.
摘要
  1. 本研究旨在解释皮下注射非典型抗精神病药物利培酮的大鼠的抗药性。这些大鼠每天以0.1毫克/千克的剂量连续注射21天(该剂量等同于用于患者的剂量),尽管大鼠因利培酮导致体温下降而食量增加,但体重并未过度增加。2. 在标准实验室条件下,采用12小时光照周期,对8周龄雄性斯普拉格-道利大鼠进行直肠温度测量。皮下注射利培酮(0.05毫克/千克)会使大鼠体温过低,这种情况在连续21天的每日注射过程中均可观察到。3. 从连续21天皮下注射利培酮(每天0.01或0.1毫克/千克)或溶剂的8周龄雄性斯普拉格-道利大鼠中提取血清、白色和棕色脂肪组织、骨骼肌和肝脏。测量血清中的脂质、酮类和甲状腺激素水平。通过定量实时聚合酶链反应扩增,研究这些组织和器官中参与产热和/或脂质代谢的物质编码基因的mRNA表达水平。4. 每天皮下注射0.1毫克/千克利培酮的大鼠血清中非酯化脂肪酸水平显著低于注射溶剂的大鼠。与注射溶剂的大鼠相比,注射利培酮的大鼠血清β-羟基丁酸水平有下降趋势。在所检测的剂量下,皮下注射利培酮对血清三碘甲状腺原氨酸和甲状腺素水平均无影响,尽管它们的值在正常范围内。5. 连续21天每天注射利培酮(0.1毫克/千克)上调了白色脂肪组织中解偶联蛋白3的mRNA表达,该蛋白以热量形式消散能量;过氧化物酶体增殖物激活受体(PPAR)γ共激活因子1α,其激活线粒体生物发生以扩展氧化机制;以及PPARα,其是脂肪细胞产热性脂肪消耗所必需的。每天注射利培酮0.1毫克/千克也增强了白色脂肪组织中脂肪生成酶(乙酰辅酶A羧化酶α、脂肪酸合酶和甘油-3-磷酸酰基转移酶)、激素敏感性脂肪酶和β1-肾上腺素能受体的mRNA表达。6. 这些发现表明,白色脂肪组织中产热的物质供应充足,这反过来会减少白色脂肪组织中脂质的储存,导致大鼠体重增加率降低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验